343
Participants
Start Date
September 6, 2017
Primary Completion Date
October 16, 2018
Study Completion Date
February 4, 2019
Placebo
Placebo was presented in identical containers, stored/packaged the same as AMG 301. All injections were administered within 30 minutes on treatment days.
AMG 301
AMG 301 was packaged in 5 mL clear glass vials containing 1 mL of 70 mg/mL of AMG 301. All injections were administered within 30 minutes on treatment days.
Research Site, Vienna
Research Site, Glostrup Municipality
Research Site, Innsbruck
Research Site, Aarhus
Research Site, Viborg
Research Site, Klagenfurt
Research Site, Berlin
Research Site, Berlin
Research Site, Plainview
Research Site, Turku
Research Site, Hamburg
Research Site, Kiel
Research Site, Greensboro
Research Site, Jacksonville
Research Site, Orlando
Research Site, West Palm Beach
Research Site, Nashville
Research Site, Memphis
Research Site, Jyväskylä
Research Site, Cleveland
Research Site, Ann Arbor
Research Site, St Louis
Research Site, City of Saint Peters
Research Site, Dallas
Research Site, Round Rock
Research Site, Austin
Research Site, Boulder
Research Site, Salt Lake City
Research Site, Oulu
Research Site, Santa Monica
Research Site, Long Beach
Research Site, East Hartford
Research Site, Stamford
Research Site, Worcester
Research Site, Calgary
Research Site, Surrey
Research Site, Markham
Research Site, Toronto
Research Site, Lévis
Research Site, Montreal
Research Site, Brno
Research Site, Prague
Research Site, Prague
Research Site, Přerov
Research Site, Helsinki
Research Site, Helsinki
Research Site, Leipzig
Research Site, Stockholm
Research Site, Stockholm
Lead Sponsor
Amgen
INDUSTRY